423 related articles for article (PubMed ID: 18842943)
1. Self-assembly of the recombinant capsid protein of a swine norovirus into virus-like particles and evaluation of monoclonal antibodies cross-reactive with a human strain from genogroup II.
Almanza H; Cubillos C; Angulo I; Mateos F; Castón JR; van der Poel WH; Vinje J; Bárcena J; Mena I
J Clin Microbiol; 2008 Dec; 46(12):3971-9. PubMed ID: 18842943
[TBL] [Abstract][Full Text] [Related]
2. Mapping broadly reactive norovirus genogroup I and II monoclonal antibodies.
Crawford SE; Ajami N; Parker TD; Kitamoto N; Natori K; Takeda N; Tanaka T; Kou B; Atmar RL; Estes MK
Clin Vaccine Immunol; 2015 Feb; 22(2):168-77. PubMed ID: 25428246
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a Norovirus-specific monoclonal antibody that exhibits wide spectrum binding activities.
Zheng L; Wang W; Liu J; Chen X; Li S; Wang Q; Huo Y; Qin C; Shen S; Wang M
J Med Virol; 2018 Apr; 90(4):671-676. PubMed ID: 29236287
[TBL] [Abstract][Full Text] [Related]
4. Novel monoclonal antibodies broadly reactive to human recombinant sapovirus-like particles.
Kitamoto N; Oka T; Katayama K; Li TC; Takeda N; Kato Y; Miyoshi T; Tanaka T
Microbiol Immunol; 2012 Nov; 56(11):760-70. PubMed ID: 22924483
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a cross-reactive linear epitope in human genogroup I and bovine genogroup III norovirus capsid proteins.
Batten CA; Clarke IN; Kempster SL; Oliver SL; Bridger JC; Lambden PR
Virology; 2006 Dec 5-20; 356(1-2):179-87. PubMed ID: 16934306
[TBL] [Abstract][Full Text] [Related]
6. Norovirus GII.17 Virus-Like Particles Bind to Different Histo-Blood Group Antigens and Cross-React with Genogroup II-Specific Mouse Sera.
Malm M; Tamminen K; Vesikari T; Blazevic V
Viral Immunol; 2018 Dec; 31(10):649-657. PubMed ID: 30431404
[TBL] [Abstract][Full Text] [Related]
7. Characterization of cross-reactive norovirus-specific monoclonal antibodies.
Kou B; Crawford SE; Ajami NJ; Czakó R; Neill FH; Tanaka TN; Kitamoto N; Palzkill TG; Estes MK; Atmar RL
Clin Vaccine Immunol; 2015 Feb; 22(2):160-7. PubMed ID: 25428247
[TBL] [Abstract][Full Text] [Related]
8. Multiple antigenic sites are involved in blocking the interaction of GII.4 norovirus capsid with ABH histo-blood group antigens.
Parra GI; Abente EJ; Sandoval-Jaime C; Sosnovtsev SV; Bok K; Green KY
J Virol; 2012 Jul; 86(13):7414-26. PubMed ID: 22532688
[TBL] [Abstract][Full Text] [Related]
9. Type-specific and cross-reactive antibodies and T cell responses in norovirus VLP immunized mice are targeted both to conserved and variable domains of capsid VP1 protein.
Malm M; Tamminen K; Vesikari T; Blazevic V
Mol Immunol; 2016 Oct; 78():27-37. PubMed ID: 27573255
[TBL] [Abstract][Full Text] [Related]
10. Cross-reactivity among sapovirus recombinant capsid proteins.
Hansman GS; Natori K; Oka T; Ogawa S; Tanaka K; Nagata N; Ushijima H; Takeda N; Katayama K
Arch Virol; 2005 Jan; 150(1):21-36. PubMed ID: 15449145
[TBL] [Abstract][Full Text] [Related]
11. Immunogenetic mechanisms driving norovirus GII.4 antigenic variation.
Lindesmith LC; Beltramello M; Donaldson EF; Corti D; Swanstrom J; Debbink K; Lanzavecchia A; Baric RS
PLoS Pathog; 2012; 8(5):e1002705. PubMed ID: 22615565
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of norovirus GII-4 antibodies in Finnish children.
Nurminen K; Blazevic V; Huhti L; Räsänen S; Koho T; Hytönen VP; Vesikari T
J Med Virol; 2011 Mar; 83(3):525-31. PubMed ID: 21264875
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a broadly reactive monoclonal antibody against norovirus genogroups I and II: recognition of a novel conformational epitope.
Shiota T; Okame M; Takanashi S; Khamrin P; Takagi M; Satou K; Masuoka Y; Yagyu F; Shimizu Y; Kohno H; Mizuguchi M; Okitsu S; Ushijima H
J Virol; 2007 Nov; 81(22):12298-306. PubMed ID: 17855545
[TBL] [Abstract][Full Text] [Related]
14. Self-assembly of the recombinant capsid protein of a bovine norovirus (BoNV) into virus-like particles and evaluation of cross-reactivity of BoNV with human noroviruses.
Han MG; Wang Q; Smiley JR; Chang KO; Saif LJ
J Clin Microbiol; 2005 Feb; 43(2):778-85. PubMed ID: 15695679
[TBL] [Abstract][Full Text] [Related]
15. Norovirus VLPs and rotavirus VP6 protein as combined vaccine for childhood gastroenteritis.
Blazevic V; Lappalainen S; Nurminen K; Huhti L; Vesikari T
Vaccine; 2011 Oct; 29(45):8126-33. PubMed ID: 21854823
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of a native epitope common to norovirus strains GII/4, GII/7 and GII/8.
Li X; Zhou R; Wang Y; Sheng H; Tian X; Li H; Qiu H
Virus Res; 2009 Mar; 140(1-2):188-93. PubMed ID: 19121346
[TBL] [Abstract][Full Text] [Related]
17. Particle conformation regulates antibody access to a conserved GII.4 norovirus blockade epitope.
Lindesmith LC; Donaldson EF; Beltramello M; Pintus S; Corti D; Swanstrom J; Debbink K; Jones TA; Lanzavecchia A; Baric RS
J Virol; 2014 Aug; 88(16):8826-42. PubMed ID: 24872579
[TBL] [Abstract][Full Text] [Related]
18. Identification of a norovirus GII-specific antigenic epitope.
Liu J; Wang Z; Ma J; Ji S; Huo Y
Arch Virol; 2024 May; 169(6):131. PubMed ID: 38819530
[TBL] [Abstract][Full Text] [Related]
19. Functionality and avidity of norovirus-specific antibodies and T cells induced by GII.4 virus-like particles alone or co-administered with different genotypes.
Malm M; Tamminen K; Heinimäki S; Vesikari T; Blazevic V
Vaccine; 2018 Jan; 36(4):484-490. PubMed ID: 29246474
[TBL] [Abstract][Full Text] [Related]
20. Norovirus GII.4 strain antigenic variation.
Lindesmith LC; Donaldson EF; Baric RS
J Virol; 2011 Jan; 85(1):231-42. PubMed ID: 20980508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
